Phyllis M. Wise
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Phyllis M. Wise has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Dena B. Dubal
Department of Physiology, University of Kentucky College of Medicine, Lexington, KY 40536, USA
4 shared publicationsKristine M. Krajnak
2 shared publicationsMelinda E. Wilson
2 shared publicationsMichael L. Kashon
2 shared publicationsShane W. Rau
Departments of *Physiology and †Biochemistry, and ‡Stroke Program of Sanders–Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY 40536; and §Women's Health Research Institute, Wyeth Ayerst Research, Radnor, PA 19087
2 shared publications- Avindra Nath
Department of Neurology, University of Kentucky, Lexington 40536-0284, USA
1 shared publication
Latest Publications
- 1 November 2001
- Published by Elsevier in Brain Research Reviews
- Vol. 37 (1-3) , 313-319
Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies
- 1 November 2001
- Published by Elsevier in Brain Research Reviews
- Vol. 37 (1-3) , 313-319
Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies
- 1 June 2001
- Published by Springer Nature in Biogerontology
- Vol. 2 (2) , 113-115
The 'menopause' and the aging brain: causes and repercussions of hypoestrogenicity
We are beginning to recognize that the regulation of reproductivesenescence in females and its consequences are more complex thanoriginally thought. We now realize that the brain plays animportant...
- 1 June 2001
- Published by Springer Nature in Biogerontology
- Vol. 2 (2) , 113-115
The 'menopause' and the aging brain: causes and repercussions of hypoestrogenicity
We are beginning to recognize that the regulation of reproductivesenescence in females and its consequences are more complex thanoriginally thought. We now realize that the brain plays animportant...
- 30 March 2001
- Published by Elsevier in Brain Research
- Vol. 898 (1) , 162-165
Localization of κ opioid receptors in oxytocin magnocellular neurons in the paraventricular and supraoptic nuclei
- 30 March 2001
- Published by Elsevier in Brain Research
- Vol. 898 (1) , 162-165
Localization of κ opioid receptors in oxytocin magnocellular neurons in the paraventricular and supraoptic nuclei
- Open Access
- 6 February 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (4) , 1952-1957
Estrogen receptor alpha , not beta , is a critical link in estradiol-mediated protection against brain injury
Estradiol protects against brain injury, neurodegeneration, and cognitive decline. Our previous work demonstrates that physiological levels of estradiol protect against stroke injury and that this protection may be mediated through receptor-dependent alterations of gene expression. In this report, we tested the hypothesis that estrogen receptors play a pivotal role in mediating neuroprotective actions of estradiol and dissected the potential biological roles of each estrogen receptor (ER) subtype, ERα and ERβ, in the injured brain. To investigate and delineate these mechanisms, we used ERα-knockout (ERαKO) and ERβ-knockout (ERβKO) mice in an animal model of stroke. We performed our studies by using a controlled endocrine paradigm, because endogenous levels of estradiol differ dramatically among ERαKO, ERβKO, and wild-type mice. We ovariectomized ERαKO, ERβKO, and the respective wild-type mice and implanted them with capsules filled with oil (vehicle) or a dose of 17β-estradiol that produces physiological hormone levels in serum. One week later, mice underwent ischemia. Our results demonstrate that deletion of ERα completely abolishes the protective actions of estradiol in all regions of the brain; whereas the ability of estradiol to protect against brain injury is totally preserved in the absence of ERβ. Thus, our results clearly establish that the ERα subtype is a critical mechanistic link in mediating the protective effects of physiological levels of estradiol in brain injury. Our discovery that ERα mediates protection of the brain carries far-reaching implications for the selective targeting of ERs in the treatment and prevention of neural dysfunction associated with normal aging or brain injury.
- 6 February 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (4) , 1952-1957
Open AccessEstrogen receptor alpha , not beta , is a critical link in estradiol-mediated protection against brain injury
Estradiol protects against brain injury, neurodegeneration, and cognitive decline. Our previous work demonstrates that physiological levels of estradiol protect against stroke injury and that this protection may be mediated through receptor-dependent alterations of gene expression. In this report, we tested the hypothesis that estrogen receptors play a pivotal role in mediating neuroprotective actions of estradiol and dissected the potential biological roles of each estrogen receptor (ER) subtype, ERα and ERβ, in the injured brain. To investigate and delineate these mechanisms, we used ERα-knockout (ERαKO) and ERβ-knockout (ERβKO) mice in an animal model of stroke. We performed our studies by using a controlled endocrine paradigm, because endogenous levels of estradiol differ dramatically among ERαKO, ERβKO, and wild-type mice. We ovariectomized ERαKO, ERβKO, and the respective wild-type mice and implanted them with capsules filled with oil (vehicle) or a dose of 17β-estradiol that produces physiological hormone levels in serum. One week later, mice underwent ischemia. Our results demonstrate that deletion of ERα completely abolishes the protective actions of estradiol in all regions of the brain; whereas the ability of estradiol to protect against brain injury is totally preserved in the absence of ERβ. Thus, our results clearly establish that the ERα subtype is a critical mechanistic link in mediating the protective effects of physiological levels of estradiol in brain injury. Our discovery that ERα mediates protection of the brain carries far-reaching implications for the selective targeting of ERs in the treatment and prevention of neural dysfunction associated with normal aging or brain injury.
- Open Access
- 1 January 2001
- Published by Springer Nature in BMC Neuroscience
- Vol. 2 (1) , 3
Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine
Human immunodeficiency virus (HIV) infection continues to increase at alarming rates in drug abusers, especially in women. Drugs of abuse can cause long-lasting damage to the brain and HIV infection frequently leads to a dementing illness.To determine how these drugs interact with HIV to cause CNS damage, we used an in vitro human neuronal culture characterized for the presence of dopaminergic receptors, transporters and estrogen receptors. We determined the combined effects of dopaminergic drugs, methamphetamine, or cocaine with neurotoxic HIV proteins, gp120 and Tat. Acute exposure to these substances resulted in synergistic neurotoxic responses as measured by changes in mitochondrial membrane potential and neuronal cell death. Neurotoxicity occurred in a sub-population of neurons. Importantly, the presence of 17beta-estradiol prevented these synergistic neurotoxicities and the neuroprotective effects were partly mediated by estrogen receptors. Our observations suggest that methamphetamine and cocaine may affect the course of HIV dementia, and additionally suggest that estrogens modify the HIV-drug interactions.
- 1 January 2001
- Published by Springer Nature in BMC Neuroscience
- Vol. 2 (1) , 3
Open AccessEstrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine
Human immunodeficiency virus (HIV) infection continues to increase at alarming rates in drug abusers, especially in women. Drugs of abuse can cause long-lasting damage to the brain and HIV infection frequently leads to a dementing illness.To determine how these drugs interact with HIV to cause CNS damage, we used an in vitro human neuronal culture characterized for the presence of dopaminergic receptors, transporters and estrogen receptors. We determined the combined effects of dopaminergic drugs, methamphetamine, or cocaine with neurotoxic HIV proteins, gp120 and Tat. Acute exposure to these substances resulted in synergistic neurotoxic responses as measured by changes in mitochondrial membrane potential and neuronal cell death. Neurotoxicity occurred in a sub-population of neurons. Importantly, the presence of 17beta-estradiol prevented these synergistic neurotoxicities and the neuroprotective effects were partly mediated by estrogen receptors. Our observations suggest that methamphetamine and cocaine may affect the course of HIV dementia, and additionally suggest that estrogens modify the HIV-drug interactions.
- 1 January 2001
- Published by Elsevier in Frontiers in Neuroendocrinology
- Vol. 22 (1) , 33-66
Estrogens: Trophic and Protective Factors in the Adult Brain
- 1 January 2001
- Published by Elsevier in Frontiers in Neuroendocrinology
- Vol. 22 (1) , 33-66
Estrogens: Trophic and Protective Factors in the Adult Brain
- 1 December 2000
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 13 (s2) , 1425-1430
Estradiol: A Protective Factor in the Adult Brain
Clinical studies suggest that estradiol acts as a protective factor in the adult brain. Postmenopausal women suffer from an increased risk of brain injury associated with neurodegenerative diseases such as Alzheimer's disease, and estrogen replacement therapy appears to decrease the risk and severity of this neurodegenerative condition. Studies using animal models show that estradiol exerts similar effects in rodents and can enhance cell survival. Therefore, we designed experiments to determine whether estradiol treatment can decrease brain injury induced by an experimental model of ischemia. Our experiments used a permanent middle cerebral artery occlusion model and physiological levels of estradiol replacement therapy. The results demonstrate that estradiol exerts profound protective effects against ischemic brain injury induced by cerebral artery occlusion and that this protective action correlates with changes in the level of gene expression of estradiol receptors and members of the Bcl-2 family. These data suggest that estrogen replacement therapy may provide important protection against age- and diseaserelated degenerative processes in the brain.
- 1 December 2000
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 13 (s2) , 1425-1430
Estradiol: A Protective Factor in the Adult Brain
Clinical studies suggest that estradiol acts as a protective factor in the adult brain. Postmenopausal women suffer from an increased risk of brain injury associated with neurodegenerative diseases such as Alzheimer's disease, and estrogen replacement therapy appears to decrease the risk and severity of this neurodegenerative condition. Studies using animal models show that estradiol exerts similar effects in rodents and can enhance cell survival. Therefore, we designed experiments to determine whether estradiol treatment can decrease brain injury induced by an experimental model of ischemia. Our experiments used a permanent middle cerebral artery occlusion model and physiological levels of estradiol replacement therapy. The results demonstrate that estradiol exerts profound protective effects against ischemic brain injury induced by cerebral artery occlusion and that this protective action correlates with changes in the level of gene expression of estradiol receptors and members of the Bcl-2 family. These data suggest that estrogen replacement therapy may provide important protection against age- and diseaserelated degenerative processes in the brain.
- Open Access
- 1 October 2000
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 63 (4) , 982-985
Estradiol Protects Against Ischemic Brain Injury in Middle-Aged Rats1
Several clinical studies suggest that estradiol acts as a potent growth and protective factor in the adult brain. Postmenopausal women experience per
- 1 October 2000
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 63 (4) , 982-985
Open AccessEstradiol Protects Against Ischemic Brain Injury in Middle-Aged Rats1
Several clinical studies suggest that estradiol acts as a potent growth and protective factor in the adult brain. Postmenopausal women experience per
- 1 December 1999
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 277 (6) , E965-E970
Neuroendocrine modulation of the “menopause”: insights into the aging brain
The menopause marks the permanent end of fertility in women. It was once thought that this dramatic physiological change could be explained simply by the exhaustion of the reservoir of ovarian follicles. New data from studies performed in women and animal models make us reassess this assumption. An increasing body of evidence suggests that there are multiple pacemakers that contribute to the transition to irregular cycles, decreasing fertility, and the timing of the menopause. We will present evidence that lends credence to the possibility that a dampening and desynchronization of the precisely orchestrated neural signals lead to miscommunication between the brain and the pituitary-ovarian axis, and that this constellation of hypothalamic-pituitary-ovarian events leads to the deterioration of regular cyclicity and heralds menopausal transition.
- 1 December 1999
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 277 (6) , E965-E970
Neuroendocrine modulation of the “menopause”: insights into the aging brain
The menopause marks the permanent end of fertility in women. It was once thought that this dramatic physiological change could be explained simply by the exhaustion of the reservoir of ovarian follicles. New data from studies performed in women and animal models make us reassess this assumption. An increasing body of evidence suggests that there are multiple pacemakers that contribute to the transition to irregular cycles, decreasing fertility, and the timing of the menopause. We will present evidence that lends credence to the possibility that a dampening and desynchronization of the precisely orchestrated neural signals lead to miscommunication between the brain and the pituitary-ovarian axis, and that this constellation of hypothalamic-pituitary-ovarian events leads to the deterioration of regular cyclicity and heralds menopausal transition.
- 1 July 1999
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 1 (4-5) , 265-274
Estradiol: A Protective and Trophic Factor in the Brain
In recent years our appreciation that estradiol is truly a pleiotropic hormone has grown dramatically. We will review the findings that suggest that estrogens 1 1 Estrogens are synthesized by the ovary and several other tissues. They contain 18 carbon atoms and an aromatized A ring. Estradiol is the predominant and most potent of the endogenously synthesized estrogens in adult premenopausal women. Preparations used in estrogen replacement therapy contain a variety of estrogenic compounds. Studies performed using laboratory animals have used a variety of estrogens to replace the endogenous steroid, including estradiol. may exert important non-reproductive actions on the brain. These studies provide important insights into the clinical effects of estrogen replacement therapy on age- and disease-related processes in the brain. We will also discuss the multiple cellular and molecular mechanisms that may underlie estradiol's neurotrophic and neuroprotective effects.
- 1 July 1999
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 1 (4-5) , 265-274
Estradiol: A Protective and Trophic Factor in the Brain
In recent years our appreciation that estradiol is truly a pleiotropic hormone has grown dramatically. We will review the findings that suggest that estrogens 1 1 Estrogens are synthesized by the ovary and several other tissues. They contain 18 carbon atoms and an aromatized A ring. Estradiol is the predominant and most potent of the endogenously synthesized estrogens in adult premenopausal women. Preparations used in estrogen replacement therapy contain a variety of estrogenic compounds. Studies performed using laboratory animals have used a variety of estrogens to replace the endogenous steroid, including estradiol. may exert important non-reproductive actions on the brain. These studies provide important insights into the clinical effects of estrogen replacement therapy on age- and disease-related processes in the brain. We will also discuss the multiple cellular and molecular mechanisms that may underlie estradiol's neurotrophic and neuroprotective effects.